Three years of growth hormone treatment in growth hormone-deficient adults: near normalization of body composition and physical performance
The DOI matches its Crossref record.
Abstract
Jørgensen JOL, Thuesen L, Müller J, Ovesen P, Skakkebæk NE, Christiansen JS. Three years of growth hormone treatment in growth hormone-deficient adults: near normalization of body composition and physical performance. Eur J Endocrinol 1994;130:224–8. ISSN 0804–4643 Growth hormone (GH) replacement therapy in several controlled short-term trials have shown unanimous beneficial effects on body composition and other features. To evaluate more long-term effects we report data from 3 years of uninterrupted GH therapy in 10 GH-deficient adults who had all completed a previous double-blind placebo-controlled study and who also had been studied after 16 months of open GH therapy. No further increase in linear height was observed. The initial increase in thigh muscle volume was maintained after 3 years of GH therapy. A slight increase in body weight and thigh fat volume was recorded. Exercise capacity and isometric muscle strength were increased significantly compared to the initial placebo period. This was associated with stabilized levels of resting heart rate and blood pressure. Glycosylated hemoglobin levels were normal and did not change during the study. A standard oral glucose tolerance test performed at the end of the study revealed no evidence of glucose intolerance. No side-effects were reported. Compared to an age- and sex-matched group of healthy untreated subjects, thigh muscle volume, exercise capacity and isometric muscle strength had become normalized from subnormal levels after 3 years of GH therapy. We conclude that long-term GH replacement therapy in GH-deficient adults is associated with preserved beneficial effects on body composition and physical performance, resulting in a near normalization of several previously abnormal features and adding new merits to this treatment modality. Jens OL Jørgensen, Medical Department M (Endocrinology and Diabetes), Aarhus Kommunehospital, DK-8000C, Denmark
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cited by
Molitch, M. E., Clemmons, D. R., Malozowski, S., Merriam, G. R., & Vance, M. L. (2011) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2011-0179 · Cited by 1,047
Growth hormone deficiency in adulthood and the effects of growth hormone replacement: a review
Carroll, P. V., Christ the members of Growth Hormon, E. R., Bengtsson, B. Å., Carlsson, L., Christiansen, J. S., Clemmons, D., Hintz, R., Ho, K., Laron, Z., Sizonenko, P., et al. (1998) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem.83.2.4594 · Cited by 822
Self-citationSchurch, M.-A., Rizzoli, R., Slosman, D., Vadas, L., Vergnaud, P., & Bonjour, J.-P. (1998) · Annals of Internal Medicine · doi:10.7326/0003-4819-128-10-199805150-00002 · Cited by 572
“Thus, low protein intake in elderly persons may be detrimental to skeletal integrity, muscle strength, and immune response (11, 24-27) because of decreased production and action of IGF-I, which favorably influences these systems (28-33).”
BackgroundEndocrine Control of Body Composition in Infancy, Childhood, and Puberty
Veldhuis, J. D., Roemmich, J. N., Richmond, E. J., Rogol, A. D., Lovejoy, J. C., Sheffield-Moore, M., Mauras, N., & Bowers, C. Y. (2005) · Endocrine Reviews · doi:10.1210/er.2003-0038 · Cited by 452
Molitch, M. E., Clemmons, D. R., Malozowski, S., Merriam, G. R., Shalet, S. M., Vance, M. L., & for The Endocrine Society’s Clinical Guidelines Subcommittee (2006) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2005-2227 · Cited by 424
Systematic review: the safety and efficacy of growth hormone in the healthy elderly
Liu, H., Bravata, D. M., Olkin, I., Nayak, S., Roberts, B., Garber, A. M., & Hoffman, A. R. (2007) · Annals of Internal Medicine · doi:10.7326/0003-4819-146-2-200701160-00005 · Cited by 370
Mechanisms of disease: metabolic effects of growth hormone and insulin-like growth factor 1
LeRoith, D., & Yakar, S. (2007) · Nature Clinical Practice Endocrinology & Metabolism · doi:10.1038/ncpendmet0427 · Cited by 344
The Effects of 10 Years of Recombinant Human Growth Hormone (GH) in Adult GH-Deficient Patients
Gibney, J. (1999) · Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.84.8.2596 · Cited by 324
Optimal management of sarcopenia
Sumukadas, D. (2010) · Clinical Interventions in Aging · doi:10.2147/cia.s11473 · Cited by 303
Growth Hormone Therapy in Adults and Children
Vance, M. L., & Mauras, N. (1999) · New England Journal of Medicine · doi:10.1056/nejm199910143411607 · Cited by 269
Growth hormone, IGF‐I and insulin and their abuse in sport
Holt, R. I. G., & Sönksen, P. H. (2008) · British Journal of Pharmacology · doi:10.1038/bjp.2008.99 · Cited by 190
“replacement showed that exercise performance continued to improve (Jorgensen et al., 1994).”
BackgroundHoffman, A. R., Kuntze, J. E., Baptista, J., Baum, H. B. A., Baumann, G. P., Biller, B. M. K., Clark, R. V., Cook, D., Inzucchi, S. E., Kleinberg, D., et al. (2004) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2003-030346 · Cited by 185
Widdowson, W. M., & Gibney, J. (2008) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2008-1239 · Cited by 107
Ten years of growth hormone (GH) replacement normalizes muscle strength in GH-deficient adults
Götherström, G., Elbornsson, M., Stibrant-Sunnerhagen, K., Bengtsson, B.-A., Johannsson, G., & Svensson, J. (2009) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2008-1538 · Cited by 85
Fisker, S., Vahl, N., Hansen, T. B., Jørgensen, J. O. L., Hagen, C., Ørskov, H., & Christiansen, J. S. (1997) · Metabolism · doi:10.1016/s0026-0495(97)90128-1 · Cited by 84
Self-citationAnderson, L. J., Tamayose, J. M., & Garcia, J. M. (2018) · Molecular and Cellular Endocrinology · doi:10.1016/j.mce.2017.06.010 · Cited by 70
Untreated growth hormone deficiency explains premature mortality in patients with hypopituitarism
Bengtsson, B.-Å. (1998) · Growth Hormone & IGF Research · doi:10.1016/s1096-6374(98)80014-2 · Cited by 22
Metadata
- Authors
- Jørgensen, J. O., Thuesen, L., Müller, J., Ovesen, P., Skakkebæk, N. E., & Christiansen, J. S.
- Venue
- European Journal of Endocrinology
- Publisher
- Oxford University Press (OUP)
- Published
- 1994-03
- Volume
- 130
- Issue
- 3
- Pages
- 224-228
- ISSN
- 0804-4643 (ISSN-L)
- 1479-683X
- OpenAlex
- W2170536472
- Cited by
- 179
- References
- 0
- FWCI
- 8.08
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.